Tech Company Financing Transactions
Garuda Therapeutics Funding Round
On 3/4/2025, Garuda Therapeutics received $50 million in Series A financing from Cormorant Asset Management, Kyowa Kirin and Northpond Ventures.
Transaction Overview
Company Name
Announced On
3/4/2025
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds for the advancement of its pipeline into the clinic, assembling an experienced team, scaling its in-house manufacturing, and other general operating activities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
22 Strathmore Rd.
Natick, MA 01760
USA
Natick, MA 01760
USA
Phone
Undisclosed
Website
Email Address
Overview
Garuda Therapeutics is developing off-the-shelf hematopoietic stem cell (HSC) therapies to treat a broad range of severe and life-threatening diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dhvanit Shah
Co-Founder
Sean Morrison
Co-Founder
David Scadden
Browse more venture capital transactions:
Prev: 3/4/2025: Osivax venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs